Denmark: Brain+ begins marketing of units to raise maximum gross proceeds of Dkr15m

Brain+, a digital medicine company that focuses on addressing Alzhemer’s and dementia, has begun marketing an issue of units ahead of listing its shares on Nasdaq First North Growth Market Denmark. Each unit consists of one share and one warrant and is offered at Dkr5.69, corresponding to a pre-money valuation for Brain+ of Dkr40m. One…

You must be a HMI Subscriber to view this content.

Subscribe Now »